abstract |
The present invention relates to novel trans-3-aza-bicyclo [3.1.0] hexane derivatives of formula (I), or pharmaceutically acceptable of such compounds, as pharmaceuticals, particularly orexin receptor antagonists. Relating to salt. [Chemical 1] In the formula, A, B, n and R 1 are as described in the specification. [Selection figure] None |